JPH0746991B2 - Virus immobilization method - Google Patents
Virus immobilization methodInfo
- Publication number
- JPH0746991B2 JPH0746991B2 JP25379586A JP25379586A JPH0746991B2 JP H0746991 B2 JPH0746991 B2 JP H0746991B2 JP 25379586 A JP25379586 A JP 25379586A JP 25379586 A JP25379586 A JP 25379586A JP H0746991 B2 JPH0746991 B2 JP H0746991B2
- Authority
- JP
- Japan
- Prior art keywords
- virus
- hollow fiber
- phage
- membrane
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000700605 Viruses Species 0.000 title claims description 99
- 238000000034 method Methods 0.000 title claims description 65
- 239000012510 hollow fiber Substances 0.000 claims description 62
- 239000012528 membrane Substances 0.000 claims description 44
- 239000011148 porous material Substances 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000004627 regenerated cellulose Substances 0.000 claims description 22
- QKSIFUGZHOUETI-UHFFFAOYSA-N copper;azane Chemical compound N.N.N.N.[Cu+2] QKSIFUGZHOUETI-UHFFFAOYSA-N 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 11
- 230000003100 immobilizing effect Effects 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 22
- 239000000706 filtrate Substances 0.000 description 20
- 239000011550 stock solution Substances 0.000 description 19
- 238000005406 washing Methods 0.000 description 18
- 229920002678 cellulose Polymers 0.000 description 17
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 16
- 239000001913 cellulose Substances 0.000 description 16
- 238000009987 spinning Methods 0.000 description 16
- 239000002245 particle Substances 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 238000001914 filtration Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108010059892 Cellulase Proteins 0.000 description 8
- 229910021529 ammonia Inorganic materials 0.000 description 8
- 229940106157 cellulase Drugs 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000002504 physiological saline solution Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000000701 coagulant Substances 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000635 electron micrograph Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229910002422 La(NO3)3·6H2O Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- -1 adsorption elution Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000004031 devitrification Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 235000020138 yakult Nutrition 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は、ウイルスが存在する液体を多孔性膜で、実質
的に垂直濾過し、ついで凍結乾燥して膜孔中にウイルス
を蛋白質などのコーティング剤なしで固定化するウイル
スの固定化方法に関する。本発明における固定化とは、
膜上に蛋白質などをコーティングすることにより達成さ
れるようなものではなく物質を多孔質膜の孔中に閉じ込
め、1ヶ所に保留して動かぬようにすることを意味す
る。本発明方法は、ウイルスの検査、例えば肝炎ウイル
スやエイズウイルスなどの免疫検査や、複数のウイルス
が混在したウイルス液から目的とするウイルスあるいは
ウイルス群を固定化することに利用できる。DETAILED DESCRIPTION OF THE INVENTION (Industrial field of application) The present invention relates to a method in which a liquid in which a virus is present is subjected to substantially vertical filtration through a porous membrane and then freeze-dried so that the virus, such as a protein, is contained in the pores of the membrane. The present invention relates to a method for immobilizing a virus that is immobilized without a coating agent. Immobilization in the present invention means
It is not something that can be achieved by coating a protein or the like on the membrane, but means that the substance is confined in the pores of the porous membrane and retained at one place so that it does not move. INDUSTRIAL APPLICABILITY The method of the present invention can be used for a virus test, for example, an immunological test for hepatitis virus or AIDS virus, and for immobilizing a target virus or virus group from a virus solution in which a plurality of viruses are mixed.
(従来技術) ウイルスは細胞内でのみ増殖し、潜在的に病原性をもつ
感染性の実体で、次のような属性をもつものである。
核酸としてDNAかRNAのどちらか一方を持つ。遺伝物質
のみ複製される。二分裂では増殖しない。エネルギ
ー産生系を欠く。宿主のリボゾームを蛋白質合成に利
用する。(Prior Art) A virus is an infectious substance that propagates only in cells and is potentially pathogenic, and has the following attributes.
It has either DNA or RNA as nucleic acid. Only the genetic material is replicated. It does not multiply in two divisions. Lack of energy production system. The host ribosome is used for protein synthesis.
現在ウイルスの濃縮方法には、粒子の大きさによる分画
遠心法、溶解度差を利用した等電点処理法、有機溶媒に
よる処理法、吸着溶出を利用した方法、粒子の形、密度
を利用した密度勾配遠心法、酸素処理による方法等があ
り、それぞれのウイルスに適した方法を選択している。
これらのうち膜を用いたウイルスの濃縮方法には、吸着
溶出を利用した方法と濾別による方法とアルギネート膜
による保留溶解による方法がある。At present, virus concentration methods include fractional centrifugation based on particle size, isoelectric point treatment using solubility differences, treatment with organic solvents, adsorption elution, particle shape and density. There are density gradient centrifugation method, oxygen treatment method, etc., and the method suitable for each virus is selected.
Among these, methods of concentrating viruses using a membrane include a method using adsorption and elution, a method by filtration, and a method by retained dissolution by an alginate membrane.
吸着溶出を利用した方法とは、適当な条件を与えウイル
ス粒子の表面荷電により吸着剤をコーティングした膜に
ウイルス粒子を吸着させ、次に塩濃度などの条件を変え
ることによってウイルス粒子をコーティングした膜より
溶出させることができることを利用した濃縮方法であ
る。例えば『Appl.Microbiol.,vol.23(4)76(197
2).,Wallis,C.et al.』に記載されているように下水な
どの水に浮遊している腸内ウイルスではあらかじめ試料
に除菌、除蛋白を行い、MgCl2あるいはAlCl3を加え、ウ
イルスをフィルターに吸着濾過させた後、溶出させてい
る。また、ウイルス培養液では液中の吸着阻止物質をプ
ロタミンなどで除去しpHを5.0に修正し濾過すると、ウ
イルスがフィルターに吸着し、次いでウシ胎児血清を濾
過すると、ウイルスが溶出し、60〜100倍の濃縮液が得
られている。しかし、一般にウイルス粒子を吸着させ、
適当な溶出液で溶出する場合は、ウイルスの感染性の低
下を起こしやすい。そのうえウイルス毎に条件を決める
必要があり、非常に操作が煩雑である。また吸着量に限
界があり、濃縮率は低い。The method using adsorption and elution is a method in which the virus particles are adsorbed on the adsorbent-coated membrane by the surface charge of the virus particles under appropriate conditions, and then the membranes coated with the virus particles by changing the conditions such as salt concentration. This is a concentration method that makes it possible to elute more. For example, “Appl. Microbiol., Vol.23 (4) 76 (197
2)., Wallis, C. et al. ”, Enteric viruses suspended in water such as sewage are sterilized and deproteinized in advance, and MgCl 2 or AlCl 3 is added. The virus is adsorbed and filtered on the filter and then eluted. Also, in the virus culture medium, the adsorption inhibitory substances in the liquid were removed with protamine and the pH was adjusted to 5.0 and filtered, and the virus was adsorbed to the filter. A double concentrate has been obtained. However, in general, the virus particles are adsorbed,
When elution is performed with an appropriate eluent, the infectivity of the virus is likely to decrease. Moreover, it is necessary to determine the conditions for each virus, and the operation is very complicated. In addition, the amount of adsorption is limited and the concentration rate is low.
次に、濾別による方法であるが、これは限外濾過による
濃縮である。『Canad.J.Chem.,vol.33,1452(1955),Go
rdon,J.L.&Mason,S.G.』に記載されているように、培
養液などの試料を循環ポンプでフィルターに平行に流
し、吸引でウイルス以外の成分をフィルターで濾過しウ
イルスを濃縮させるものである。これはフィルターに蛋
白質が吸着するため目づまりがしやすく、ウイルスの濃
縮速度は遅い。また、種々の形や大きさを持つウイルス
に適した孔径の膜を選択することはできない。Next, a method by filtration, which is concentration by ultrafiltration. `` Canad.J.Chem., Vol.33,1452 (1955), Go
As described in “Rdon, JL & Mason, SG”, a sample such as a culture solution is caused to flow in parallel to a filter by a circulation pump, and components other than the virus are filtered by aspiration to concentrate the virus. This is because the protein is adsorbed on the filter, so that it is easily clogged and the virus concentration rate is slow. Further, it is not possible to select a membrane having a pore size suitable for viruses having various shapes and sizes.
次にアルギネート膜による方法であるが、『ウイルス実
験学、総論(国立予防衛生研究所学友会編)丸善(197
3)、p47』に記載されているように、この膜はアルギン
酸ナトリウムの溶液にLa(NO3)3・6H2O,AlCl3・6H2O
を加えてゲル化したもので、三層(capillaryzone,inte
rmediatelayer,primary gel membrane)からなるもので
ある。ウイルスを、このフィルターに保留させ融解して
回収し、動物または培養細胞によるウイルス分離を行う
ものである。このフィルターにおいてウイルスは中間層
に保留される。しかし、ゲル状であるため、もろく、非
常に取り扱いにくく、保留できるウイルス量は限定され
てくる。しかも、濾過後保留されたウイルスを乾燥状態
で保存しておくことは不可能である。またフィルターを
融解してウイルスを回収しなければならず、ウイルスの
感染性の低下も起こしやすい。このように、アルギネー
ト膜による方法は実用的ではないといえる。Next, regarding the method using an alginate membrane, “Muscle virus research, general review (National Institute of Preventive Health, alumni association) Maruzen (197
3), p47 ”, this film was added to a solution of sodium alginate to produce La (NO 3 ) 3 · 6H 2 O, AlCl 3 · 6H 2 O.
Gelled by adding three layers (capillary zone, inte
rmediatelayer, primary gel membrane). The virus is retained in this filter, thawed and recovered, and the virus is separated by animals or cultured cells. In this filter virus is retained in the middle layer. However, since it is gel-like, it is brittle, very difficult to handle, and the amount of virus that can be reserved is limited. Moreover, it is impossible to store the virus retained after filtration in a dry state. In addition, the filter must be thawed and the virus must be recovered, and the infectivity of the virus is likely to decrease. Thus, it can be said that the method using an alginate film is not practical.
(発明が解決しようとする問題点) ウイルスの濃縮を行う場合、従来の方法ではウイルスの
感染性を維持することと濃縮効率を高めることの2つを
同時に満足することは難しかった。かつウイルスは多く
の場合液体中で浮遊状態にあり、常に空気中への飛散の
可能性があるが、有害ウイルスを取り扱う場合において
人体に対する安全性は考慮されていなかった。(Problems to be Solved by the Invention) When a virus is concentrated, it has been difficult for the conventional methods to simultaneously satisfy the two requirements of maintaining the infectivity of the virus and enhancing the efficiency of concentration. Moreover, in many cases, the virus is suspended in a liquid and may be scattered in the air at all times, but the safety to the human body has not been considered when handling harmful viruses.
本発明の目的は、ウイルスの種類にかかわらず、ウイル
スの感染性を維持しながら濃縮でき、しかも、取り扱い
操作がより簡単で安全性の高いウイルスの固定化方法を
提供することである。It is an object of the present invention to provide a method for immobilizing a virus that can be concentrated while maintaining the infectivity of the virus regardless of the type of virus, and that is easy to handle and highly safe.
(問題点を解決するための手段) 本発明方法は、ウイルスの存在する液体を、銅アンモニ
ア法再生セルロースからなる多孔性膜で実質的に垂直濾
過し、しかる後、凍結乾燥して、膜孔中にウイルスを固
定化することを特徴とする。(Means for Solving Problems) In the method of the present invention, a liquid in which a virus is present is subjected to substantially vertical filtration with a porous membrane made of regenerated cellulose having a copper-ammonia method, and then freeze-dried to obtain a membrane pore. It is characterized by immobilizing the virus inside.
再生セルロースの製法には、ビスコース法、セルロース
エステルのケン化法、銅アンモニア法など、種々のもの
があるが、それぞれ、製造条件の相違により物理的、科
学的な性質に差があり、『再生セルロース』として一律
に論じられるものではない。銅アンモニア法では、不可
欠な酸処理により銅の除去に伴う微細な孔の発生と特異
な分子鎖の凝集構造の発生が認められるため、銅アンモ
ニア法再生セルロースは特異な性質を持つ。There are various methods for producing regenerated cellulose, such as the viscose method, the saponification method of cellulose ester, and the copper ammonia method. However, there are differences in physical and scientific properties due to differences in production conditions. It is not uniformly discussed as "regenerated cellulose". In the copper-ammonia method, the generation of fine pores and the formation of a unique molecular chain aggregate structure due to the removal of copper are recognized by the indispensable acid treatment, and therefore the copper-ammonia method regenerated cellulose has a unique property.
その性質の特徴は親水性で、かつ蛋白質の吸着性が少な
い点にある。本発明者らは、蛋白質と高分子素材との吸
着性に関する相関性を検討した結果、一般的には、親水
性素材ほど、蛋白質の吸着性が小さく、本発明方法に用
いられる銅アンモニア法再生セルロースからなる多孔性
中空繊維が1番小さいことを見いだした。Its characteristic feature is that it is hydrophilic and has low protein adsorption. The present inventors have examined the correlation regarding the adsorptivity between the protein and the polymer material, and as a result, in general, the hydrophilic material has a lower protein adsorptivity, and the copper-ammonia method regeneration used in the method of the present invention It has been found that the porous hollow fiber made of cellulose is the smallest.
銅アンモニア法再生セルロースの粘度平均分子量は7×
104以上が好ましく、また0.1N NaOH水溶液中での溶解成
分が少なければ少ないほど望ましい。40℃、48時間、0.
1N NaOH水溶液中に浸漬した際、この溶解分が10ppm以下
であれば、この中空繊維はウイルスを濃縮するのに最も
適している。Viscosity average molecular weight of regenerated cellulose with copper ammonia method is 7 ×
It is preferably 10 4 or more, and the smaller the dissolved component in the 0.1N NaOH aqueous solution, the more preferable. 40 ° C, 48 hours, 0.
This hollow fiber is most suitable for concentrating viruses when it is immersed in 1N NaOH aqueous solution and the dissolved content is 10 ppm or less.
上述のようなセルロースからなる膜を作製するには、高
純度なセルロース原液を用いて銅アンモニア法再生セル
ロースを作製するか、あるいは膜を作製後に0.1N NaOH
水溶液で72時間以上洗浄処理すれば良い。高純度セルロ
ース原料を用いれば、上記溶解分が著しく減少するの
で、より好ましい。ここで、『高純度セルロース原料』
とは、α−セルロース含有量が95wt%以上で、重合度が
500以上の木綿リンターおよび木材パルプを指す。これ
らの原料について、ブリーチング、洗浄工程中での分解
および酸化を防止つつ、不純物の混入を避けるため、常
に精製された水を用いると良い。To make a film made of cellulose as described above, use a high-purity cellulose stock solution to make regenerated cellulose by the cuprammonium method, or use 0.1N NaOH after making the film.
It may be washed with an aqueous solution for 72 hours or more. The use of a high-purity cellulose raw material is more preferable because the dissolved content is significantly reduced. Here, "high-purity cellulose raw material"
Means that the α-cellulose content is 95 wt% or more and the degree of polymerization is
Over 500 cotton linters and wood pulp. For these raw materials, it is preferable to always use purified water in order to prevent bleaching, decomposition and oxidation during the washing process, and avoid mixing of impurities.
銅アンモニア法再生セルロースからなる多孔性膜でのウ
イルス固定化に際して、ウイルス径V(nm)、膜の水流
速平均孔径D(nm)、膜厚T(μm)とすると、 の条件を満たすことが好ましい。When immobilizing a virus on a porous membrane made of regenerated cellulose by the cuprammonium method, assuming that the virus diameter is V (nm), the average water flow velocity pore diameter is D (nm), and the membrane thickness is T (μm), It is preferable to satisfy the condition of.
ここで、ウイルス径Vとは、球状ウイルスではその直径
を、また、非球状ウイルスでは、楕円体に近似したとき
の短軸の直径を差す。(1)式の値が9.5以上である
と、膜のウイルス阻止率が高く、膜孔中にウイルスが浸
入することができない。Here, the virus diameter V refers to the diameter of a spherical virus, and the diameter of the minor axis when approximated to an ellipsoid for a non-spherical virus. When the value of the formula (1) is 9.5 or more, the virus blocking rate of the membrane is high, and the virus cannot penetrate into the membrane pores.
また、(1)式の値が1より小さいとウイルスの損失が
多く、多孔性膜を構成する物質(ウイルスの媒体とよ
ぶ、原液では水が、膜中に補捉されたウイルスでは膜を
構成する再生セルロースが媒体である)1g当たりのウイ
ルス密度をウイルス原液1g(=1ml)あたりのウイルス
密度より大きくすることが出来ない。If the value of the formula (1) is less than 1, the loss of virus is large, and the substance that constitutes the porous membrane (called the medium of virus, water in the undiluted solution, the membrane in the case of virus trapped in the membrane The regenerated cellulose used as the medium) cannot increase the virus density per 1 g higher than the virus density per 1 g of virus stock solution (= 1 ml).
膜によるウイルス粒子の分離機構としては、膜の孔径の
大きさと分離すべきウイルス粒子の粒子径との違いによ
りふるい分ける『ふるい機構』と、膜表面にウイルス粒
子を吸着させる『吸着機構』がある。銅アンモニア法再
生セルロースからなる多孔性膜では、蛋白質の吸着性が
他の高分子素材にくらべて、最も小さいという本発明者
らの検討結果を考慮すれば、銅アンモニア法再生セルロ
ースからなる多孔性膜によるウイルス分離は、殆ど『ふ
るい機構』であると考えられる。As the separation mechanism of virus particles by the membrane, there are a "sieving mechanism" that sifts according to the difference between the pore size of the membrane and the particle diameter of the virus particles to be separated, and "adsorption mechanism" that adsorbs the virus particles on the membrane surface. . Considering the results of the study by the present inventors that the adsorption property of protein is the smallest in the porous membrane made of the copper-ammonia method regenerated cellulose as compared with other polymer materials, the porous membrane made of the copper-ammonia method regenerated cellulose is considered. Viral separation by membranes is considered to be mostly a "sieving mechanism".
多孔性膜としては、平膜でも中空繊維でも使用できる
が、好ましくは中空繊維である。As the porous membrane, either a flat membrane or a hollow fiber can be used, but a hollow fiber is preferable.
銅アンモニア法再生セルロースからなる多孔性中空繊維
において、内壁面から外壁面への膜厚方向に垂直な面に
おける孔径を面内平均孔径で表す時、膜内貫通孔の入口
及び出口における面内平均孔径の間に、極小の部分、該
極小の部分より大きい部分、もうひとつの極小の部分の
順に配列された構造が、中空繊維の膜厚方向に少なくと
も1組存在するものを用いるとよい。ここで言う極小と
は、数学的意味での極小をさす。すなわち、本発明にお
いては、膜表面の面内平均孔径がそのすぐ内側面の面内
平均孔径より小さいような膜は、「膜表面は極小の部
分」とはいわない。In the porous hollow fiber made of regenerated cellulose by the cuprammonium method, when the pore diameter in the plane perpendicular to the film thickness direction from the inner wall surface to the outer wall surface is expressed by the in-plane average pore diameter, the in-membrane average at the inlet and outlet of the through-membrane hole It is preferable to use a structure in which at least one set in the thickness direction of the hollow fiber has a structure in which a minimum portion, a portion larger than the minimum portion, and another minimum portion are arranged in this order between the pore diameters. The minimum mentioned here refers to the minimum in a mathematical sense. That is, in the present invention, a membrane in which the in-plane average pore diameter of the membrane surface is smaller than the in-plane average pore diameter of the immediately inner surface thereof is not said to be a "minimal membrane surface portion".
この構造により、従来の多孔質中空繊維にくらべて、銅
アンモニア法再生セルロースからなる多孔性中空繊維の
ウイルスの阻止率を高くすることができ、孔中にウイル
スを補捉できると共に、濾過速度を速めることができ
る。これに対して、面内平均孔径の極小部が少なくとも
1組以上存在しない多孔性中空繊維の場合では、阻止率
を90%以上にするには、透過速度を遅くせざるを得ず、
またウイルスを中空繊維孔中に補捉し、濃縮することは
できない。With this structure, compared with the conventional porous hollow fiber, it is possible to increase the virus blocking rate of the porous hollow fiber made of regenerated cellulose by the copper ammonia method, trap the virus in the pores, and increase the filtration rate. You can speed it up. On the other hand, in the case of a porous hollow fiber in which at least one set of minimum in-plane average pore diameter does not exist, the permeation rate must be slowed in order to achieve a blocking rate of 90% or more.
Also, the virus cannot be trapped in the hollow fiber pores and concentrated.
銅アンモニア法再生セルロースからなる多孔性中空繊維
において、極小面内空孔率は10%以上であることが好ま
しい。10%未満では、限外濾過速度は急激に低下する。
好ましくは30%以上である。限外濾過速度に及ぼす面内
空孔率の影響は、10%未満では極小面内空孔率の5乗、
10〜30%では約2乗、30%を越えると約1乗に比例して
限外濾過速度は増加する。一方、極小面内空孔率が80%
を越えると、多孔性中空繊維の力学的性質は著しく低下
し、ピンホール等の欠陥部が生じたり、中空繊維を構成
するセルロース分子が、濾液中あるいは被濾過液中に脱
落分散する恐れがある。In the porous hollow fiber made of regenerated cellulose by the cuprammonium method, the minimum in-plane porosity is preferably 10% or more. Below 10%, the ultrafiltration rate drops sharply.
It is preferably 30% or more. The effect of the in-plane porosity on the ultrafiltration rate is as follows:
The ultrafiltration rate increases in proportion to about the second power at 10 to 30% and to the first power at more than 30%. On the other hand, the minimum in-plane porosity is 80%
If it exceeds, the mechanical properties of the porous hollow fiber may be remarkably deteriorated, and a defect such as a pinhole may be generated, or the cellulose molecules constituting the hollow fiber may be dropped and dispersed in the filtrate or the liquid to be filtered. .
中空繊維の膜厚は薄ければ薄いほど、一般的には濾過速
度が大きくなるので好ましい。しかしながら、膜厚が10
μm未満になると、中空繊維にはピンホールが多発し、
ウイルス粒子が濾液中に漏れ出てくる。また膜厚が100
μm以上になると、濾過速度が大きく低下してしまう。
極小面内空孔率が大きくなれば膜厚をより厚く設計する
方が被補捉ウイルス数が増加して良い。The thinner the thickness of the hollow fiber is, the more preferable it is because the filtration rate is generally increased. However, the film thickness is 10
When it is less than μm, pinholes frequently occur in the hollow fiber,
Viral particles leak out into the filtrate. Also the film thickness is 100
If it is more than μm, the filtration rate will be significantly reduced.
If the minimum in-plane porosity is large, the number of trapped viruses may be increased by designing a thicker film thickness.
本発明方法に用いられる銅アンモニア法再生セルロース
からなる多孔性中空繊維は、該中空繊維の内壁面から外
壁面への膜厚方向に層状構造を有し、蛋白質の透過性、
ウイルスの阻止性、ウイルスの補捉性をより支配する極
小部を有している。その極小部分の膜厚方向での厚み
は、該多孔性中空繊維が、ミクロ相分離法で作製される
ため、セルロース濃厚相粒子の直径に相当する。したが
って、その厚みは2μm以下である。The porous hollow fiber made of the cuprammonium method regenerated cellulose used in the method of the present invention has a layered structure in the film thickness direction from the inner wall surface to the outer wall surface of the hollow fiber, and has protein permeability,
It has a minimal part that further controls virus blocking and virus trapping properties. The thickness of the extremely small portion in the film thickness direction corresponds to the diameter of the cellulose dense phase particles because the porous hollow fiber is produced by the micro phase separation method. Therefore, its thickness is 2 μm or less.
本発明方法で用いられる銅アンモニア法再生セルロース
からなる多孔性中空繊維の製造方法としては、例えば、
セルロースリンター(α−セルロース含有量96%以上、
平均分子量2.6×105)を公知の方法で調整した銅アンモ
ニア溶液中に8wt%の濃度で溶解したものを紡糸原液と
して用いる。この紡糸原液に対して、アセトン/アンモ
ニア/水系混合溶液を凝固剤および中空剤として用いて
ミクロ相分離を生起させ、その後、凝固、再生すること
により得られる。ここで、ミクロ相分離とは、溶液中に
高分子の濃厚層あるいは希薄層が直径0.02〜数μmの粒
子として分散し、安定化している状態を意味する。ミク
ロ相分離の生起は、紡糸中の糸の失透現象によって直接
肉眼観察するか、あるいは紡糸後の糸の電子顕微鏡観察
により、直径1μm以下、0.02μm以上の粒子の存在で
確認される。Examples of the method for producing a porous hollow fiber made of regenerated cellulose of the copper-ammonia method used in the method of the present invention include:
Cellulose linter (α-cellulose content 96% or more,
A solution obtained by dissolving an average molecular weight of 2.6 × 10 5 ) in a copper ammonia solution prepared by a known method at a concentration of 8 wt% is used as a spinning stock solution. This spinning dope is obtained by using an acetone / ammonia / water mixed solution as a coagulant and a hollowing agent to cause microphase separation, and then coagulating and regenerating. Here, the micro phase separation means a state in which a concentrated layer or diluted layer of a polymer is dispersed in a solution as particles having a diameter of 0.02 to several μm and is stabilized. The occurrence of microphase separation can be confirmed by direct visual observation of the devitrification phenomenon of the yarn during spinning, or by electron microscopic observation of the yarn after spinning, in the presence of particles having a diameter of 1 μm or less and 0.02 μm or more.
凍結乾燥は、公知の方法を採用することができる。凍結
温度は低いほど、また凍結させるまでの時間は短かいほ
ど、ウイルスの感染性を維持するためには好ましい。例
えば、ウイルスを補捉した中空繊維を液体窒素中で瞬間
的に凍結させ、直ちに真空中で乾燥をはじめるなどの方
法が望ましい。濾過後、速やかに凍結させるためには、
モジュールを解体して中空繊維を取り出さずに、モジュ
ールの形態のままで凍結させることか望ましい。凍結乾
燥前にモジュールを解体することは中空繊維への雑菌汚
染の程度を増大させて、その後の無菌条件下で使用が困
難になるばかりでなく、ウイルスの感染力が低下するの
で、好ましくない。A known method can be used for freeze-drying. The lower the freezing temperature and the shorter the freezing time, the better for maintaining the infectivity of the virus. For example, a method is preferred in which the hollow fibers trapped with viruses are instantaneously frozen in liquid nitrogen and immediately dried in vacuum. In order to freeze immediately after filtration,
It is desirable to freeze the module in its form, without disassembling the module and removing the hollow fibers. Disassembling the module before freeze-drying is not preferable because it not only increases the degree of contamination of hollow fibers with bacteria and makes it difficult to use it under aseptic conditions thereafter, but also reduces virus infectivity.
本発明方法による実施例を説明するに先立ち、本明細書
中に用いられる主な技術用語(物性値)の定義とその測
定方法を以下に示す。Prior to the description of the examples according to the method of the present invention, the definitions of the main technical terms (physical property values) used in the present specification and the measuring methods thereof will be shown below.
[水流速平均孔径] 銅アンモニア法再生セルロースからなる多孔性中空繊維
のモジュールを作製し、そのモジュール状態で、中空繊
維の水の流出量を測定し、(2)式から水流速平均孔径
を求めた。[Water Flow Rate Average Pore Diameter] A porous hollow fiber module made of regenerated cellulose prepared by the copper-ammonia method was prepared, and the outflow amount of water from the hollow fiber was measured in the module state, and the water flow rate average pore diameter was calculated from the equation (2). It was
V:流出量(ml/min) T:膜厚(μm) ΔP:圧力差(mmHg) A:膜面積(m2) Prρ:空孔率(−) μ:水の粘性率(cP) 空孔率Prρは水膨潤時の見掛け密度ρaw、ポリマーの密
度ρpより(3)式で求めた。セルロースの場合ρp=
1.561を用いた。 V: Outflow rate (ml / min) T: Film thickness (μm) ΔP: Pressure difference (mmHg) A: Membrane area (m 2 ) Prρ: Porosity (−) μ: Water viscosity (cP) Porosity The ratio Prρ was calculated by the equation (3) from the apparent density ρaw at the time of water swelling and the polymer density ρp. In the case of cellulose, ρp =
1.561 was used.
Prρ(%)=(1−ρaw/ρp)×100 (3) [平均分子量] 銅アンモニア溶液中(20℃)で測定された極限粘度数
[η](ml/g)を(4)式に代入することにより平均分
子量(粘度平均分子量)Mvを算出する。Prρ (%) = (1-ρaw / ρp) × 100 (3) [Average molecular weight] Intrinsic viscosity number [η] (ml / g) measured in copper ammonia solution (20 ° C) The average molecular weight (viscosity average molecular weight) Mv is calculated by substituting.
Mv=[η]×3.2×103 (4) [極小面内空孔率] 銅アンモニア法再生セルロースからなる多孔性中空繊維
をアクリル樹脂で包埋後、ウルトラミクロトーム(LKB
社(スウェーデン)製UltratomeIII8800型)に装着した
ガラスナイフをもちいて、外壁面から膜厚方向に沿って
厚さ約1μmの試料を順に切り出す。その試料切片をク
ロロホルムで脱包埋後、それぞれの切片の電子顕微鏡写
真をとる。注目する切片の1cm2当たり、孔半径が
(r)〜(r+dr)に存在する孔の数をN(r)drと表
示する。3次および4次の平均孔半径(それぞれ3お
よび4)は次式で定義される。Mv = [η] × 3.2 × 10 3 (4) [Minimum in-plane porosity] After embedding porous hollow fiber made of regenerated cellulose with copper ammonia method with acrylic resin, ultra microtome (LKB
Using a glass knife attached to a company (Sweden Ultratome III8800 type), samples with a thickness of about 1 μm are sequentially cut out from the outer wall surface along the film thickness direction. The sample sections are deembedded with chloroform, and then electron micrographs of each section are taken. The number of pores having a radius of (r) to (r + dr) per 1 cm 2 of the target slice is indicated as N (r) dr. The third and fourth order average pore radii (3 and 4, respectively) are defined by the following equations.
平均孔径は (5)式および(6)式から計算される。それぞれの切
片の電子顕微鏡写真より平均孔径を計算し、面内平均孔
径の内壁面からの距離に対する図示より、極小面内孔径
を示す面を決定する。その決定された面の空孔率を極小
面内空孔率と定義する。その極小面内空孔率は(7)式
で求められる。 Average pore size is It is calculated from the equations (5) and (6). The average pore size is calculated from the electron micrograph of each section, and the plane showing the minimum in-plane pore size is determined from the drawing of the average in-plane pore size from the inner wall surface. The porosity of the determined surface is defined as the minimum in-plane porosity. The minimum in-plane porosity is calculated by the equation (7).
[ウイルス阻止係数] 濾過しようとする水溶液単位体積当たりのウイルスの数
No,膜を透過した濾液単位体積当たりのウイルスの数N
のとき下記(8)式で定義される。 [Virus inhibition coefficient] Number of viruses per unit volume of aqueous solution to be filtered
No, number of viruses per unit volume of filtrate permeated through membrane N
Then, it is defined by the following equation (8).
φ=−log(N/No) (8) (発明の効果) 本発明によれば、ウイルスが存在する液体から、ウイル
スの感染性を低下させることなく、かつ人体により安全
に、ウイルスを固定化して濃縮することが出来る。そし
て、血清肝炎ウイルスやエイズウイルスのような感染す
るウイルスの免疫検査を中空繊維の孔中にウイルスを固
定した状態で行える。また、複数のウイルスが混在した
ウイルス液から目的とするウイルスあるいはウイルス群
を分別あるいは固定化濃縮することに利用できる。φ = −log (N / No) (8) (Effect of the invention) According to the present invention, a virus is immobilized from a liquid in which the virus is present in the human body safely without lowering the infectivity of the virus. Can be concentrated. Then, an immunological test for infectious viruses such as serum hepatitis virus and AIDS virus can be performed with the virus fixed in the pores of the hollow fiber. In addition, it can be used for separating or immobilizing a target virus or virus group from a virus solution in which a plurality of viruses are mixed.
(実施例) 以下、本発明方法によるウイルスの固定化方法の実施例
を示す。(Example) Hereinafter, an example of a method for immobilizing a virus according to the method of the present invention will be described.
(実施例1) セルロースリンター(α−セルロース含有量96%以上、
平均分子量2.6×105)を公知の方法で調整した銅アンモ
ニア溶液中に8wt%の濃度で分解し、濾過脱泡を行い、
紡糸原液とした。その紡糸原液を環状紡糸口の外側紡出
口(外径2mmφ)より2.5ml/minで、一方中空剤として、
アセトン45wt%/アンモニア0.575wt%/水54.425wt%
の混合溶液(中空剤)を中央紡出口(外径0.6mmφ)よ
り1.7ml/minでそれぞれアセトン45wt%/アンモニア0.5
75wt%/水54.425wt%の混合溶液(凝固剤)中に直接吐
出し、12m/minの速度で巻き取った。なお、吐出直後の
透明青色状の繊維状物は次第に白色化し、ミクロ相分離
を生起し、ひきつづいて凝固が起こり、繊維としての形
状が維持されていた。その後、2wt%の硫酸水溶液で再
生し、その後、水洗した。水洗後の中空繊維をアセトン
で、中空繊維内部の水分を置換し、その後、10%延伸し
た状態で真空乾燥した(25℃×1.5時間)。このように
して得られた銅アンモニア法再生セルロース多孔性中空
繊維の内径は300.2μm、膜厚は28.5μm、水流速平均
孔径は10.8nm、極小面内空孔率は28%であった。(1)
式より計算された値は9.4であった。(Example 1) Cellulose linter (α-cellulose content of 96% or more,
The average molecular weight of 2.6 × 10 5 ) was decomposed in a copper ammonia solution adjusted by a known method at a concentration of 8 wt%, and filtered and defoamed,
This was the spinning dope. The spinning dope is 2.5 ml / min from the outer spinning outlet (outer diameter 2 mmφ) of the annular spinning port, while as a hollowing agent,
Acetone 45wt% / Ammonia 0.575wt% / Water 54.425wt%
45wt% of acetone / 0.5mm of ammonia at 1.7ml / min from the central spinning outlet (outer diameter 0.6mmφ)
It was directly discharged into a mixed solution (coagulant) of 75 wt% / water 54.425 wt% and wound at a speed of 12 m / min. The transparent blue fibrous material immediately after discharge gradually became white, microphase separation occurred, and subsequently solidification occurred, and the shape as a fiber was maintained. Then, it was regenerated with a 2 wt% sulfuric acid aqueous solution and then washed with water. The hollow fiber after washing with water was replaced with acetone to replace the water content inside the hollow fiber, and then vacuum-dried in a 10% stretched state (25 ° C. × 1.5 hours). The thus obtained copper-ammonia method regenerated cellulose porous hollow fiber had an inner diameter of 300.2 μm, a film thickness of 28.5 μm, a water flow average pore diameter of 10.8 nm, and a minimal in-plane porosity of 28%. (1)
The value calculated from the formula was 9.4.
大腸菌ファージφ×174(IFO20009、ウイルス径25nm)
を大腸菌(IFO13898)に感染させファージ原液を調製し
た。ファージ濃度を寒天重層法によりプラーク形成数か
ら測定したところ、1.9×109(PFU/ml)であった。上記
銅アンモニア法再生セルロース中空繊維100本よりなる
ガラス製ミニモジュールの入口より上記ファージ原液を
中空繊維中空部に送入し、中空部出口を閉じた状態で、
ファージ原液11mlを圧力200mmHgで濾過し、濾液5mlを得
た。濾液1ml中のファージ濃度をプラーク法で定量した
が、ファージは確認されなかった。従って、φは9.2以
上であった。続いてモジュール出口を開き、生理食塩水
をペリスタリックポンプで毎分10mlの流量でモジュール
に送入しながら、膜にかかる圧力が約200mmHgになるよ
う調節して中空部および孔内を十分に洗浄した。洗浄終
了直前の濾液および中空部を通過した洗浄液中にはプラ
ーク形成法によりファージは確認されなかった。モジュ
ール洗浄後、モジュールをそのまま液体窒素中で凍結さ
せ、東京理化器機(株)製凍結乾燥器(FD−1)のチャ
ンバー内にいれ、24時間、中空繊維を凍結乾燥した。Coliphage φ × 174 (IFO20009, virus diameter 25nm)
Was infected with E. coli (IFO13898) to prepare a phage stock solution. The phage concentration was 1.9 × 10 9 (PFU / ml) as determined from the number of plaques formed by the agar overlay method. The phage stock solution was fed into the hollow portion of the hollow fiber through the inlet of the glass mini-module consisting of 100 copper-ammonia method regenerated cellulose hollow fibers, with the hollow portion outlet closed,
11 ml of the phage stock solution was filtered at a pressure of 200 mmHg to obtain 5 ml of the filtrate. The phage concentration in 1 ml of the filtrate was quantified by the plaque method, but no phage was confirmed. Therefore, φ was 9.2 or more. Next, open the module outlet, and while supplying physiological saline to the module with a peristaltic pump at a flow rate of 10 ml per minute, adjust the pressure applied to the membrane to about 200 mmHg and thoroughly wash the hollow part and the inside of the hole. did. No phage was confirmed by the plaque formation method in the filtrate immediately before the end of washing and in the washing liquid that passed through the hollow portion. After the module was washed, the module was frozen in liquid nitrogen as it was, placed in a chamber of a freeze dryer (FD-1) manufactured by Tokyo Rikaki Co., Ltd., and the hollow fiber was freeze dried for 24 hours.
中空繊維孔中に補捉されたファージ量を測定するため
に、凍結乾燥した中空繊維約100mg(中空繊維で40本)
を0.5%セルラーゼ溶液(pH5.0,0.1N酢酸緩衝液にヤク
ルト製オノズカR−10を溶解)10ml中に37℃で浸漬して
セルロースを分解し、pHを7.0に調整後、分解液を9000
r.p.mで10分間遠心し、上澄液中のファージ濃度をプラ
ーク法で測定した。中空繊維に固定されていたファージ
が大腸菌に感染して明瞭なプラークを形成したことか
ら、ファージはその感染性が維持されたまま孔中に固定
されていたことが確認できた。上澄液中のファージ濃度
は、3.8×107(PFU/ml)であった。したがって中空繊維
1g中に3.8×109PFUのファージが存在しており、媒体1g
中のウイルス密度は原液より高くなっていた。About 100 mg of freeze-dried hollow fibers (40 hollow fibers) to measure the amount of phage trapped in the hollow fiber pores
Was dissolved in 10 ml of 0.5% cellulase solution (pH 5.0, 0.1N acetic acid buffer solution dissolved in Yakult's Onozuka R-10) at 37 ° C to decompose the cellulose, and the pH was adjusted to 7.0.
After centrifugation at rpm for 10 minutes, the phage concentration in the supernatant was measured by the plaque method. Since the phages immobilized on the hollow fibers were infected with Escherichia coli and formed clear plaques, it was confirmed that the phages were immobilized in the pores while maintaining their infectivity. The phage concentration in the supernatant was 3.8 × 10 7 (PFU / ml). Thus hollow fibers
There are 3.8 × 10 9 PFU of phage in 1g, and 1g of medium
The virus density inside was higher than the stock solution.
(比較例1) セルロース濃度10%、アンモニア濃度7%、銅濃度3.6
%の組成と2000ポイズの粘度を有する銅アンモニア再生
セルロース原液を、2重環状紡口の外側紡出口(外径5m
m)から20ml/minで押し出し、同時に中央の直径1mmの管
からパークロルエチレンを5ml/minで押し出した。次に
押し出された線状紡糸原液を直接空気中に300mm自由落
下させ、次いで11wt%NaOH水溶液に導入し、8mの凝固浴
を巻き取り速度100m/minで通過させた。凝固浴から引き
出した糸は水洗後、3%硫酸で再生し、再び水洗した。
その後130℃で乾燥し、つづいて中空部内の有機溶媒を
押し出した。このようにして得た中空繊維の内径は265
μm、膜厚25μm、水流速平均孔径は8nm、面内空孔率
は10%以下であった。(1)式から計算した値は9.7で
あった。(Comparative Example 1) Cellulose concentration 10%, ammonia concentration 7%, copper concentration 3.6
%, And a viscosity of 2000 poises of a copper ammonia regenerated cellulose stock solution was added to the outer side of the double annular spinneret (outer diameter 5 m
m) at 20 ml / min, and at the same time, perchlorethylene was extruded at 5 ml / min from a central tube having a diameter of 1 mm. Next, the extruded linear spinning dope was dropped directly into the air by 300 mm, then introduced into an 11 wt% NaOH aqueous solution, and passed through an 8 m coagulation bath at a winding speed of 100 m / min. The yarn drawn from the coagulation bath was washed with water, regenerated with 3% sulfuric acid, and then washed again with water.
Then, it was dried at 130 ° C., and then the organic solvent in the hollow portion was extruded. The hollow fiber thus obtained has an inner diameter of 265
μm, film thickness 25 μm, average pore size of water flow velocity was 8 nm, and in-plane porosity was 10% or less. The value calculated from the equation (1) was 9.7.
実施例1と同様のファージ原液を濾過し、濾液5mlを得
た。濾液中にはプラーク法によりファージは確認されな
かった。実施例と同様にセルラーゼ処理で中空繊維を分
解し、遠心上澄みのファージ濃度をプラーク法で定量し
たところ、ファージは確認されなかった。従って、ファ
ージは中空繊維孔中にはほとんど補捉されていなかっ
た。The same phage stock solution as in Example 1 was filtered to obtain 5 ml of filtrate. No phage was confirmed in the filtrate by the plaque method. When the hollow fibers were decomposed by cellulase treatment in the same manner as in Example and the concentration of phage in the centrifugal supernatant was quantified by the plaque method, no phage was confirmed. Therefore, the phage was hardly trapped in the hollow fiber pores.
(実施例2) 以下の条件で実施例1と同様に多孔性中空繊維を作製し
た。セルロース濃度;7%、中空剤組成;アセトン/アン
モニア/水=40/0.56/59.44、凝固剤組成;中空剤組成
と同じ、中空剤吐出速度;2.2ml/min,紡糸原液吐出速度;
2.2ml/min.、紡糸速度10m/min.。得られた中空繊維の内
径は238.4μm、膜厚は29.0μm、平均孔径48.6μm、
極小面内空孔率は30.2%であった。(1)式より計算し
た値は1.2であった。(Example 2) A porous hollow fiber was produced in the same manner as in Example 1 under the following conditions. Cellulose concentration: 7%, hollow agent composition; acetone / ammonia / water = 40 / 0.56 / 59.44, coagulant composition; same as hollow agent composition, hollow agent discharge rate; 2.2 ml / min, spinning dope discharge rate;
2.2 ml / min., Spinning speed 10 m / min. The hollow fiber obtained had an inner diameter of 238.4 μm, a film thickness of 29.0 μm, an average pore diameter of 48.6 μm,
The minimum in-plane porosity was 30.2%. The value calculated from the equation (1) was 1.2.
実施例1と同様にφ×174のファージ原液(ファージ濃
度7.3×107PFU/mlを濾過した。濾液中のウイルス濃度は
7.1×106PFU/mlであった。したがって、φは1.01であっ
た。実施例1と同様に生理食塩水で十分に洗浄した後、
凍結乾燥した。洗浄終了時の濾液中にはファージが確認
されなかった。Phage stock solution of φ × 174 (phage concentration 7.3 × 10 7 PFU / ml was filtered in the same manner as in Example 1. The virus concentration in the filtrate was
It was 7.1 × 10 6 PFU / ml. Therefore, φ was 1.01. After thoroughly washing with physiological saline as in Example 1,
Lyophilized. No phage was found in the filtrate at the end of washing.
実施例1と同様にセルラーゼ処理をし、中空繊維孔中に
補捉されたファージ量を測定したところ、遠心分離上澄
液中のファージ濃度は7.9×105PFU/mlであった。したが
って中空繊維1g中に7.9×107PFUのファージが存在して
いた。従って、媒体1g中のファージ密度は原液より高く
なっていた。Cellulase treatment was carried out in the same manner as in Example 1, and the amount of phage trapped in the hollow fiber pores was measured. As a result, the concentration of phage in the centrifugal supernatant was 7.9 × 10 5 PFU / ml. Therefore, 7.9 × 10 7 PFU of phage was present in 1 g of the hollow fiber. Therefore, the phage density in 1 g of the medium was higher than that of the stock solution.
(実施例3) 以下の条件で実施例1と同様に多孔性中空繊維を作製し
た。セルロース濃度;8%、中空剤組成;アセトン/アン
モニア/水=45/0.575/54.425、凝固剤組成;中空剤組
成と同じ、中空剤吐出速度;1.7ml/min,紡糸原液吐出速
度;2.5ml/min.,紡糸速度10m/min.。得られた中空繊維の
内径は310.84μm、膜厚は22.9μm、平均孔径20.9μ
m、極小面内空孔率は27.5%であった。(1)式より計
算した値は4.4であった。(Example 3) A porous hollow fiber was produced in the same manner as in Example 1 under the following conditions. Cellulose concentration: 8%, hollow agent composition; acetone / ammonia / water = 45 / 0.575 / 54.425, coagulant composition; same as hollow agent composition, hollow agent discharge rate; 1.7 ml / min, spinning dope discharge rate; 2.5 ml / min., spinning speed 10m / min. The obtained hollow fiber had an inner diameter of 310.84 μm, a film thickness of 22.9 μm, and an average pore diameter of 20.9 μm.
m, and the minimum in-plane porosity was 27.5%. The value calculated from the equation (1) was 4.4.
実施例1と同様にφ×174のファージ原液(ファージ濃
度1.1×1010PFU/ml)を濾過した。濾液中のウイルス濃
度は7.9×105PFU/mlであった。したがって、φは4.1で
あった。実施例1と同様に生理食塩水で十分に洗浄した
後、凍結乾燥した。洗浄終了時の濾液および中空部を通
過した洗浄液中にはファージが確認されなかった。In the same manner as in Example 1, the φ × 174 stock solution of phage (phage concentration 1.1 × 10 10 PFU / ml) was filtered. The virus concentration in the filtrate was 7.9 × 10 5 PFU / ml. Therefore, φ was 4.1. It was thoroughly washed with physiological saline as in Example 1, and then freeze-dried. At the end of washing, no phage was confirmed in the filtrate and the washing solution that passed through the hollow portion.
実施例1と同様にセルラーゼ処理をし、中空繊維構造体
中に補捉されたファージ量を測定したところ、遠心分離
上澄液中のファージ濃度は2.1×108PFU/mlであった。従
って、中空繊維1g中に2.1×1010PFUのファージが存在し
ていた。従って、媒体1g中のファージ密度は、原液より
高くなっており、ファージは中空繊維孔中に濃縮されて
補捉されていた。Cellulase treatment was carried out in the same manner as in Example 1, and the amount of phage trapped in the hollow fiber structure was measured. As a result, the concentration of phage in the centrifugation supernatant was 2.1 × 10 8 PFU / ml. Therefore, 2.1 × 10 10 PFU of phage was present in 1 g of the hollow fiber. Therefore, the phage density in 1 g of the medium was higher than that in the stock solution, and the phage were concentrated and trapped in the hollow fiber pores.
(実施例4) 実施例2と同様の多孔性中空繊維を用いた。大腸菌ファ
ージとしてT4ファージ(IFO20004)宿主菌として大腸菌
(IFO13168)を用いた。T4のウイルス径は85nmとした。
従って、(1)式より計算した値は1.3であった。ファ
ージ原液のファージ濃度は9.5×109(PFU/ml)であっ
た。この原液を実施例1と同様に濾過した。濾液中のウ
イルス濃度は4.3×106(PFU/ml)であった。従って、φ
は3.3であった。分離に引き続いて実施例1と同様に生
理食塩水で十分に洗浄した後、凍結乾燥した。洗浄終了
時の濾液および中空部を通過した洗浄液中にはファージ
が確認されなかった。Example 4 The same porous hollow fiber as in Example 2 was used. T4 phage (IFO20004) was used as an E. coli phage, and E. coli (IFO13168) was used as a host bacterium. The virus diameter of T4 was 85 nm.
Therefore, the value calculated from the equation (1) was 1.3. The phage concentration of the phage stock solution was 9.5 × 10 9 (PFU / ml). This stock solution was filtered as in Example 1. The virus concentration in the filtrate was 4.3 × 10 6 (PFU / ml). Therefore, φ
Was 3.3. Subsequent to the separation, washing was carried out with a physiological saline solution in the same manner as in Example 1, followed by freeze-drying. At the end of washing, no phage was confirmed in the filtrate and the washing solution that passed through the hollow portion.
実施例1と同様にセルラーゼ処理をし、中空繊維孔中に
補捉されたファージ量を測定したところ、遠心分離上澄
液中のファージ濃度は1.2×108PFU/mlであった。従っ
て、中空繊維1g中に1.2×1010PFUのファージが存在して
いた。Cellulase treatment was carried out in the same manner as in Example 1, and the amount of phage trapped in the hollow fiber pores was measured. As a result, the concentration of phage in the centrifugation supernatant was 1.2 × 10 8 PFU / ml. Therefore, 1.2 × 10 10 PFU of phage was present in 1 g of the hollow fiber.
以上と全く同じ中空繊維とファージ原液を用いて、同じ
条件で濾過と洗浄を行った。中空繊維を凍結乾燥せずに
室温(25℃)で24時間真空乾燥、あるいは24時間室内放
置(風乾)した。洗浄時の濾液及び中空部を通過した洗
浄液中にはファージは確認されなかった。実施例と同様
にセルラーゼ処理して中空繊維孔中に補捉されたファー
ジ量を測定したところ、遠心分離上澄液中のファージ濃
度はそれぞれ3.7×107PFU/ml(真空乾燥)、2.3×106PF
U/ml(風乾)であった。従って、中空繊維1g中にそれぞ
れ3.7×109PFU(真空乾燥)、2.3×108PFU(風乾)しか
感染性のあるファージが存在していなかった。Using the same hollow fiber and phage stock solution as above, filtration and washing were performed under the same conditions. The hollow fiber was vacuum-dried at room temperature (25 ° C) for 24 hours without freeze-drying, or left indoors (air-dried) for 24 hours. No phage was found in the filtrate during washing and the washing liquid that passed through the hollow portion. When the amount of phage trapped in the hollow fiber pores was measured by cellulase treatment in the same manner as in Example, the phage concentration in the centrifugation supernatant was 3.7 × 10 7 PFU / ml (vacuum dried), 2.3 ×. 10 6 PF
It was U / ml (air dried). Therefore, infectious phages were present in only 3.7 × 10 9 PFU (vacuum dried) and 2.3 × 10 8 PFU (air dried) in 1 g of the hollow fiber, respectively.
(比較例2) 以上の条件で実施例1と同様に多孔性中空繊維を作製し
た。セルロース濃度;7%、中空剤組成;アセトン/アン
モニア/水=40/0.56/59.44、凝固剤組成;中空剤組成
と同じ、中空剤吐出速度;3.5ml/min,紡糸原液吐出速度;
2.2ml/min.、紡糸速度10m/min.。得られた中空繊維は膜
厚は19.2μm、平均孔径56.3nmであった。(1)式より
計算した値は0.5であった。(Comparative Example 2) A porous hollow fiber was produced under the above conditions in the same manner as in Example 1. Cellulose concentration: 7%, hollow agent composition; acetone / ammonia / water = 40 / 0.56 / 59.44, coagulant composition; same as hollow agent composition, hollow agent discharge rate; 3.5 ml / min, spinning dope discharge rate;
2.2 ml / min., Spinning speed 10 m / min. The resulting hollow fiber had a film thickness of 19.2 μm and an average pore diameter of 56.3 nm. The value calculated from the equation (1) was 0.5.
実施例1と同様にφ×174のファージ原液(ファージ濃
度6.3×109(PFU/ml)を濾過した。濾液中のウイルス濃
度は1.8×109(PFU/ml)であった。したがって、φは0.
5であった。実施例1と同様に生理食塩水で十分に洗浄
した後、凍結乾燥した。洗浄終了時の濾液および中空部
を通過した洗浄液中にはファージが確認されなかった。In the same manner as in Example 1, φ × 174 stock solution of phage (phage concentration 6.3 × 10 9 (PFU / ml) was filtered. The virus concentration in the filtrate was 1.8 × 10 9 (PFU / ml). is 0.
Was 5. It was thoroughly washed with physiological saline as in Example 1, and then freeze-dried. At the end of washing, no phage was confirmed in the filtrate and the washing solution that passed through the hollow portion.
実施例1と同様にセルラーゼ処理をし、中空繊維孔中に
補捉されたファージ量を測定したところ、遠心分離上澄
液中のファージ濃度は3.3×107PFU/mlであった。したが
って中空繊維1g中に3.3×109PFUのファージが存在して
いた。媒体1g中のファージ密度は原液より低くなった。Cellulase treatment was carried out in the same manner as in Example 1, and the amount of phage trapped in the hollow fiber pores was measured. As a result, the concentration of phage in the centrifugal supernatant was 3.3 × 10 7 PFU / ml. Therefore, 3.3 × 10 9 PFU of phage was present in 1 g of the hollow fiber. The phage density in 1 g of medium was lower than that of the stock solution.
(実施例5) セルロースリンター(α−セルロース含有量96%以上、
平均分子量2.6×105)を公知の方法で調整した銅アンモ
ニア溶液中に8wt%の濃度で溶解した。この溶液を25℃
のアセトン/アンモニア蒸気雰囲気下に置かれたガラス
板上に均一に流延し、該雰囲気下に1分間から10分間放
置した後、20℃のアセトン25wt%/2.8%アンモニア水2w
t%/水73wt%の混合溶液にガラス板ごと10分間から60
分間浸漬し、その後20℃の2wt%硫酸水溶液中に10分間
浸漬後、水洗し、しかる後、水分をろ紙ですい取り、20
℃のアセトン(100wt%)中に15分間浸漬し、膜中の水
分をアセトンで置換し、ろ紙にはさんで風乾し、平均孔
径を異にする再生セルロース多孔平膜を得た。(Example 5) Cellulose linter (α-cellulose content of 96% or more,
An average molecular weight of 2.6 × 10 5 ) was dissolved at a concentration of 8 wt% in a copper ammonia solution prepared by a known method. This solution at 25 ℃
After uniformly casting on a glass plate placed in an acetone / ammonia vapor atmosphere of 1 to 10 minutes under the atmosphere, 2 wt of acetone 25 wt% / 2.8% ammonia water at 20 ° C.
Glass plate in a mixed solution of t% / 73 wt% water for 10 minutes to 60
Soak for 20 minutes, then soak in a 2wt% sulfuric acid aqueous solution at 20 ° C for 10 minutes, wash with water, and then rinse with a filter paper to remove water.
The membrane was immersed in acetone (100 wt%) at ℃ for 15 minutes, the water content in the membrane was replaced with acetone, and it was sandwiched between filter papers and air-dried to obtain regenerated cellulose porous flat membranes having different average pore diameters.
得られた膜は、平均孔径63nm、膜厚133μmであった。
(1)式より計算した値は4.0であった。この膜をミリ
ポア製ステンレスフィルターホルダーに装着し、実施例
4と同じT4ファージの原液(2×107PFU/ml)を圧力200
mmHgで垂直濾過し、濾液5mlを得た。濾液中のウイルス
濃度は3.2×102(PFU/ml)、φは4.8であった。次いで
生理食塩水で十分に水洗した後、実施例1と同様に凍結
乾燥した。洗浄時の濾液中にファージは確認されなかっ
た。実施例1と同様にセルラーゼ処理して、膜中に補捉
されているファージ量を定量したところ、膜1g中に3.9
×107PFUのファージが補捉されていた。The obtained film had an average pore size of 63 nm and a film thickness of 133 μm.
The value calculated from the equation (1) was 4.0. This membrane was mounted on a Millipore stainless steel filter holder, and the same stock solution of T4 phage (2 × 10 7 PFU / ml) as in Example 4 was applied at a pressure of 200.
Vertical filtration was performed with mmHg to obtain 5 ml of a filtrate. The virus concentration in the filtrate was 3.2 × 10 2 (PFU / ml) and φ was 4.8. Then, after thoroughly washing with physiological saline, it was freeze-dried as in Example 1. No phage was found in the filtrate during washing. Cellulase treatment was carried out in the same manner as in Example 1 to quantify the amount of phage trapped in the membrane.
Phage of × 10 7 PFU were captured.
Claims (2)
厚T(μm)が10≦T≦100で(1)式を満足する銅ア
ンモニア法再生セルロールからなる多孔性中空繊維を用
いて、ウイルス径V(nm)のウイルスが存在する液体
を、実質的に垂直濾過して、該ウイルスを該膜孔中に補
捉し、しかる後に凍結乾燥して孔中に該ウイルスを固定
化することを特徴とするウイルスの固定化方法。 (ただし、Dは水流速平均孔径D(nm)を表す)1. A porosity comprising a copper-ammonia method regenerated cell roll having a minimum in-plane porosity Pr (%) of 10 ≦ Pr ≦ 80 and a film thickness T (μm) of 10 ≦ T ≦ 100 and satisfying the formula (1). A liquid containing a virus having a virus diameter of V (nm) is substantially vertically filtered using a hollow hollow fiber to trap the virus in the pores of the membrane, and then freeze-dried into the pores. A method for immobilizing a virus, which comprises immobilizing the virus. (However, D represents water flow velocity average pore diameter D (nm))
における面内平均孔径の間に、極小の部分、該極小の部
分より大きい部分、もうひとつの極小の部分の順に配列
された構造を膜厚方向に少なくとも1組有する銅アンモ
ニア法再生セルロースからなる多孔性中空繊維である特
許請求の範囲第1項記載のウイルスの固定化方法。2. A porous membrane is arranged in the order of a minimum portion, a portion larger than the minimum portion, and another minimum portion between the in-plane average pore diameters at the inlet and the outlet of the in-membrane through-hole. The method for immobilizing a virus according to claim 1, which is a porous hollow fiber made of regenerated cellulose having a copper-ammonia method having at least one set of the above structure in the film thickness direction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25379586A JPH0746991B2 (en) | 1986-10-27 | 1986-10-27 | Virus immobilization method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25379586A JPH0746991B2 (en) | 1986-10-27 | 1986-10-27 | Virus immobilization method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63109780A JPS63109780A (en) | 1988-05-14 |
| JPH0746991B2 true JPH0746991B2 (en) | 1995-05-24 |
Family
ID=17256255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25379586A Expired - Lifetime JPH0746991B2 (en) | 1986-10-27 | 1986-10-27 | Virus immobilization method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0746991B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4764972B2 (en) | 2003-12-03 | 2011-09-07 | 大学共同利用機関法人情報・システム研究機構 | Multiwell plate |
| JP2023150352A (en) * | 2022-03-31 | 2023-10-16 | 花王株式会社 | virus concentrate material |
-
1986
- 1986-10-27 JP JP25379586A patent/JPH0746991B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63109780A (en) | 1988-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3474205B2 (en) | Polysulfone hollow fiber type blood purification membrane and method for producing the same | |
| US4808315A (en) | Porous hollow fiber membrane and a method for the removal of a virus by using the same | |
| JP6024660B2 (en) | Porous hollow fiber membrane | |
| JPWO1998052683A1 (en) | Polysulfone-based hollow fiber blood purification membrane and its manufacturing method | |
| RU2718981C1 (en) | Membrane for virus removal and method for production of membrane for virus removal | |
| US5240615A (en) | Composite membrane composed of microporous polyvinylidene difluoride membrane laminated to porous support and process for its preparation | |
| JPWO2001014047A1 (en) | Filtration membrane for physiologically active substance solutions | |
| JP5857407B2 (en) | Hollow fiber membrane and method for producing hollow fiber membrane | |
| JPH10108907A (en) | Membrane for hemocatharsis, its preparation and module for hemocatharsis | |
| JP2804055B2 (en) | Preparation method of non-infectious substance containing virus antigen or antibody | |
| CN118909068A (en) | Method for preparing controllable high-concentration silk fibroin solution by tangential flow ultrafiltration technology | |
| US4857196A (en) | Porous hollow fiber membrane and a method for the removal of a virus by using the same | |
| JP2832835B2 (en) | Virus removal method | |
| JP3314861B2 (en) | Hollow fiber membrane | |
| JPH0746991B2 (en) | Virus immobilization method | |
| JP3093821B2 (en) | Method for producing regenerated cellulose porous hollow fiber membrane by cuprammonium method | |
| JP4683402B2 (en) | Hollow fiber membrane for blood purification, method for producing the same, and blood purifier | |
| JP5722098B2 (en) | Porous particles, method for producing porous particles, and carrier | |
| JPH03228671A (en) | Porous regenerated cellulose membrane for removing mycoplasma and removal of mycoplasma | |
| JP2003175321A (en) | Method for manufacturing hollow fiber membrane | |
| JPH01254204A (en) | Method for removing virus | |
| JPH10337445A (en) | Virus removing method | |
| JPS63161972A (en) | Regenerated cellulose porous membrane for separating and concentrating aids virus | |
| JP2003275300A (en) | Regenerated cellulose hollow fiber membrane for blood purification, its manufacturing method, and blood purifying apparatus | |
| JPS6388130A (en) | Production of blood plasma free from hepatitis b virus |